Structures and inhibition of the Crimean–Congo haemorrhagic fever virus polymerase

Ergönül, Ö. Crimean–Congo haemorrhagic fever. Lancet Infect. Dis. 6, 203–214 (2006).

Hawman, D. W. & Feldmann, H. Crimean–Congo haemorrhagic fever virus. Nat. Rev. Microbiol. 21, 463–477 (2023).

Feng, J. et al. Discovery of a macrocyclic influenza cap-dependent endonuclease inhibitor. J. Med. Chem. 67, 2570–2583 (2024).

Tchesnokov, E. P., Bailey-Elkin, B. A., Mark, B. L. & Götte, M. Independent inhibition of the polymerase and deubiquitinase activities of the Crimean–Congo hemorrhagic fever virus full-length L-protein. PLoS Negl. Trop. Dis. 14, e0008283 (2020).

Welch, S. R. et al. Identification of 2′-deoxy-2′-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus. Antiviral Res. 147, 91–99 (2017).

Muzammil, K. et al. Recent advances in Crimean-Congo hemorrhagic fever virus detection, treatment, and vaccination: overview of current status and challenges. Biol. Proced. Online 26, 20 (2024).

Fanelli, A. & Buonavoglia, D. Risk of Crimean Congo haemorrhagic fever virus (CCHFV) introduction and spread in CCHF-free countries in southern and Western Europe: a semi-quantitative risk assessment. One Health 13, 100290 (2021).

Malet, H., Williams, H. M., Cusack, S. & Rosenthal, M. The mechanism of genome replication and transcription in bunyaviruses. PLoS Pathog. 19, e1011060 (2023).

Gerlach, P., Malet, H., Cusack, S. & Reguera, J. Structural insights into bunyavirus replication and its regulation by the vRNA promoter. Cell 161, 1267–1279 (2015).

Arragain, B. et al. Pre-initiation and elongation structures of full-length La Crosse virus polymerase reveal functionally important conformational changes. Nat. Commun. 11, 3590 (2020).

... continue reading